Biologics

Drug name

Indication

Stage: Phase 1

Phase 2

Phase 3

CC-90006

Psoriasis

MSB11022

Psoriasis

ABY-035/AFO2

Psoriasis

M1095/ALX-0761

Psoriasis

Namilumab (MT203)

Psoriasis

SHR-1314

Psoriasis

Tildrakizumab (MK-3222/
SCH 900222/SUNPG1623)

PsA

BCD-057

Psoriasis

BCD-085

Psoriasis and PsA

BI695501

Psoriasis

Bimekizumab (UCB4940)

Psoriasis and PsA

CHS-1420

Psoriasis

GP2017

Psoriasis

Mirikizumab (LY3074828)

Psoriasis

PF-06438179

Psoriasis

Oral Treatments

Drug name

Indication

Stage: Phase 1

Phase 2

Phase 3

ABBV-157

Psoriasis

CC-92252

Psoriasis

EDP1066

Psoriasis

EDP1815

Psoriasis

Apo805K1

Psoriasis

BI 730357

Psoriasis

FP187

Psoriasis

JTE-451

Psoriasis

KD025 (SLx-2119)

Psoriasis

PF-06826647

Psoriasis

Prurisol

Psoriasis

XP23829

Psoriasis

ZPL-389

Psoriasis

BMS-986165

Psoriasis and PsA

CF101 (piclidenoson)

Psoriasis

Filgotinib (GLPG0634)

PsA

LAS41008

Psoriasis

Serlopitant (VPD-737)

Psoriasis

Upadacitinib (ABT-494)

PsA

Topicals

Drug name

Indication

Stage: Phase 1

Phase 2

Phase 3

BOS-475

Psoriasis

ARQ-151

Psoriasis

EISO (SAN021)

Psoriasis

Eucrisa (crisaborole/AN2728)

Psoriasis​

LAS41004

Psoriasis​

PF-06700841

Psoriasis and PsA

PH-10

Psoriasis​

SNA-120 (CT 327/pegcantratinib)

Psoriasis

M518101

Psoriasis​

MC2-01 Cream

Psoriasis

Tapinarof (DVMT-505)

Psoriasis​